The present invention relates to the collection of body fluids, particularly urine, and to a method of automated collection and analysis.
Male urinary collection and analysis is common for medical reasons. This is managed in the prior art with absorbent diapers, indwelling urinary catheters and/or external, non-invasive urine collection devices. Diapers are associated with a high rate of skin breakdown and decubitis ulcer formation while indwelling urinary catheters are a leading cause of urinary tract infections. Accordingly, there has been a great demand for non-invasive external incontinence devices for collecting human urine without exposing the body to continuous urine contact. To avoid leakage, prior art external, non-invasive devices for collecting urine, as exemplified by U.S. Pat. No. 5,263,947 to Kay, U.S. Pat. No. 5,827,247 to Kay and U.S. Pat. No. 5,830,932 to Kay, have incorporated a para-metal seal formed of a ring or annular arrangement of leaves or petals carried by a urine drainage housing and adapted to be adhesively secured to the end of the penis to produce a seal preventing leakage of urine. To enhance the seal, additional sealing layers have been proposed; however, such sealing layers are frequently applied incorrectly when the application requires that the individual applying the device independently establishes an optimal accurate application of the additional sealing layer(s). Application of the additional sealing layer(s) is commonly inaccurate, with the additional sealing layer(s) being applied too proximal or too distal to other sealing layer(s) or with inadequate alignment to achieve an optimal bilaminar seal. Each additional sealing layer must be applied in a specific spatial orientation with respect to previously applied sealing layers, to optimize the leak free duration of each device application. Therefore, there is a need for an external incontinence device which can be applied with a consistent spatial orientation to allow leak-free use especially for females. Furthermore, there is a need for a collection device with analytic capabilities.
Brief Discussion of Related Analytics
These devices are known in applications for sensing protein, screening for diseases, detection of Nanocantilevers point mutations, blood glucose monitoring, detection of chemical and biological warfare agents, and have been used in nanoelectromechanical systems. Molecules adsorbed on a microcantilever cause vibrational frequency changes and deflection. Viscosity, density, and flow rate can be measured by detecting these physical changes. This development has increased the sensitivity limit to the extent that researchers can now visualize the counting of molecules. With the ability of high throughput analysis of analytes and ultra-sensitive detection, this technology holds promise for the next generation of miniaturized and highly sensitive sensors. Molecular diagnostic devices are getting smaller with the advancement of miniaturization techniques. There is increasing interest in the field of biosensor research on miniaturized platforms. Miniaturization is essential for in-vivo physiological monitoring, multiple specificity sensor arrays, sensor portability and minimized sample volumes. Conventional biosensors need extensive packaging, complex electronic interfacing and regular maintenance. These new micro-sensors have advantages over conventional analytical techniques in terms of high sensitivity, low cost, simple procedure, low analyte requirement, non-hazardous procedures and quick response.
Sodium Chloride: A poly-silicon nanowire is used to sense and measure sodium chloride concentration in solution. The Department of Communications Engineering, at Yuan Ze University, Taiwan, has developed a NaCl concentration; ion sensitive field-effect transistor; using poly-silicon nanowires. This sensor was fabricated by top-down technique for sodium chloride concentration measurement. The results showed that the smallest threshold voltage and the best resolution were 1.65 V and 0.41 μM, respectively. This sensor is able to be reused more than 50 times while maintaining acceptable performance and showed good linearity of calibration within a wide range of concentrations. Based on these results, the proposed sensor has potential to be used for measuring complicated samples with suitable modification on the surface of nanowires.
Moisture: In yet another development, Professor Alan Lakso of Cornell University has engineered a micro-chip which is able to hold water in a small cavity and exchange moisture from that cavity with moisture in its environment via a nano-porous membrane. The chip measures any changes in the pressure within the cavity that result from water entering or being drawn out. In order to relay the data it gathers, the chip may be wired to a Wi-Fi card, a data logger, or other device for gathering and transmitting information. The chip can last outdoors for at least a few years, although freezing temperatures may cause failure.
Liquid Level: For liquid level sensing, optical infrared devices are commercially available and can be used to replace mechanical type float switches while providing high precision level control. These devices have compact construction with no moving parts so as to provide high reliability. They meet or exceed all common safety standard and are RoHS compliant. Alternately, ITV pk of the UK produces a water level sensor part number 6336 commonly used for this intended purpose.
Occult Blood: For occult blood detection, optical sensors are available, as for example from Sonotec Products, EU. to detect the smallest amounts of blood in dialysates on transparent tubes non-invasively. As the wavelength is adapted to the transmittance of blood, the international standard IEC 60601-2-16:2008 for medical electrical devices is fulfilled reliably. Hence, these sensors are able to detect as small as 0.04% of blood in an isotonic saline solution. For instance, one such commercially available detector meets high safety standards and features a serial interface. With simple commands, this sensor can be tested and sensitivity level adjusted. Such a device is suitable for all tasks that require the optical detection of transmission differences of liquids in transparent tubes. Due to the high sensitivity of these sensors it is even possible to detect when a tube filled with a clear fluid runs empty.
Drugs: The Amedicheck Panel Urine Drug Testing Cup is available through TransMed Co. LLC, Cumming, Ga. This device is used to determine the presence of the following substances: Marijuana (THC), Opiates (OPI), Methamphetamines (METH), Cocaine (COC), Phencyclidine (PCP), Amphetamines (AMP), Oxycodone (OXY), Barbiturates (BAR), Benzodiazepine (BZO), Methadone (MTD), Tricyclic Antidepressants (TCA), and Ecstasy (MDMA).
Proteins: Recently, numerous biosensors for detecting specific biomolecules such as DNA, proteins and antibody-antigen have been studied for a clinical and industrial demand with the progress of life science. There has been considerable attention directed to protein molecules since the occurrence of disease is well known at this level. Even though several techniques for the detection of proteins such as optical, mass spectrometry, and electrochemical measurement are in existence, field effect transistor based biosensors, which are fabricated by semiconductor integrated circuit techniques, have lately attracted attention because of its various advantages in miniaturization, standardization, mass-production and especially suitable configuration for an on-chip integration of both the sensor and measurement system. A gate field effect transistor biosensor for the detection of streptavidin-biotin protein complexes in a silicon micro-fluidic channel has been developed. The connection between this device and a micro-fluidic system could be achieved offering merits of isolation between the device and solution, compatibility with integrated circuit technology and applicability to the micro total analysis system. Such a device was fabricated combining semiconductor integrated circuit and micro-electromechanical system techniques.
The presently described apparatus includes a urine tube and a canister. The urine tube is adapted for joining with the human urethra, either male or female, and as such, enables reception of urine discharges. Suction of about 5 inches Hg is produced within the apparatus. This suction enables the temporary joining between the interface portion and the urethra. The apparatus is worn at times when urination is expected or desired and may be disconnected and removed from, and reconnected to an individual at will. The urine tube is adapted by size for receiving an individual's penis or with a flared end to engage a female urethra where in both cases suction is used for engagement. Once sealed, the suction source may be released while leaving a light vacuum within the urine tube thereby maintaining the seal. In both the male and female approach, suction within the tube may be released at any time by releasing suction. However, suction is present during urination which will send urine into the urine canister. A liquid sensor signals when urine is present. This produces a higher suction level within the urine tube, drawing the urine into the canister. When the liquid sensor no longer senses the presence of liquid, the vacuum generator closes-down while leaving a low-level suction for maintaining connection of the urine tube to the urethra. Sensors within the canister are able to detect substances within the urine. For instance, using known sensors and analytic techniques: Quantitative analysis of occult blood, proteins, glucose, drugs, and various chemical compositions can be determined. This information is delivered to a digital processor for data logging and analysis including plotting values against time. Comparison of measured values relative to standards, enables prediction of medical conditions including illness. Therefore, it is an object of the invention to maintain a tube at a urethra outlet. It is another object to provide a means for allowing urination to occur without interrupting a person's sleep or activities. It is a further object to continuously monitor a patient's biological signs through urine sampling and analysis. It is a still further object to collect urine in a system that is low cost, easily operated, and portable to be useful by paramedics in the field. These and other aspects of embodiments herein described will be better appreciated when considered in conjunction with the following description and the accompanying drawings. It should be understood, however, that the following descriptions, while indicating preferred embodiments and numerous specific details thereof, are given by way of illustration and not of limitation. Changes and modifications may be made within the scope of the embodiments herein presented without departing from the spirit thereof. Unless otherwise indicated expressions of singularity shall include plurality and vice-versa, while expressions of the alternative shall be considered nonexclusive.
Illustrations in the drawing sheets presented herein are examples only and should not be taken as limiting. The same reference numeral refers to the same element as it may appear in multiple figures and drawing sheets.
As shown in the attached drawing figures, a collector-analyzer apparatus includes an interface portion 110 (
As shown in
In
In
It should be recognized that the described apparatus may be adapted for use with animals other than humans. For instance, there is a need for taking and analyzing urine samples of farm animals such horses, mules, cows, and non-farm animals and other mammals.
In this description, embodiments are described as a plurality of individual parts, and methods as a plurality of individual steps and this is solely for the sake of illustration. Accordingly, it is contemplated that some additional parts or steps may be added, some parts or steps may be changed or omitted, and the order of the parts or steps may be rearranged, while maintaining the sense and understanding of the apparatus and methods as claimed.
Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57. This application is a continuation of U.S. application Ser. No. 15/416,272, filed Jan. 26, 2017, which is a continuation-in-part of U.S. application Ser. No. 15/412,049, filed Jan. 22, 2017. U.S. application Ser. No. 15/416,272 claims the benefit of U.S. Provisional No. 62/297,096, filed Feb. 18, 2016. Each of the above-listed disclosure are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
660388 | Moberg et al. | Oct 1900 | A |
1742080 | Jones | Dec 1929 | A |
2483079 | Williams | Sep 1949 | A |
2571357 | Charles | Oct 1951 | A |
2698016 | Andrade et al. | Dec 1954 | A |
2739595 | Coles | Mar 1956 | A |
2763266 | Evans | Sep 1956 | A |
2842129 | Ernstorff | Jul 1958 | A |
2867215 | Horton et al. | Jan 1959 | A |
2873740 | Wainwright | Feb 1959 | A |
3116734 | Terman | Jan 1964 | A |
3194238 | Breece, Jr. | Jul 1965 | A |
3349768 | Xavier | Oct 1967 | A |
3424163 | Gravdahl | Jan 1969 | A |
3528423 | Lee | Sep 1970 | A |
3601125 | Moss | Aug 1971 | A |
3683914 | Crowley | Aug 1972 | A |
3742953 | Lee | Jul 1973 | A |
3906952 | Zamist | Sep 1975 | A |
3918433 | Fuisz | Nov 1975 | A |
4023571 | Comerford et al. | May 1977 | A |
4194508 | Anderson | Mar 1980 | A |
4198979 | Cooney et al. | Apr 1980 | A |
4200102 | Duhamel et al. | Apr 1980 | A |
4246901 | Frosch et al. | Jan 1981 | A |
4270539 | Frosch et al. | Jun 1981 | A |
4425130 | DesMarais | Jan 1984 | A |
4610675 | Truinfol | Sep 1986 | A |
4631061 | Martin | Dec 1986 | A |
4664663 | Brier | May 1987 | A |
4747166 | Kuntz | May 1988 | A |
4795449 | Schneider et al. | Jan 1989 | A |
4882794 | Stewart | Nov 1989 | A |
5049144 | Payton | Sep 1991 | A |
5195997 | Carns | Mar 1993 | A |
5267969 | Hirsch et al. | Dec 1993 | A |
5312379 | Rahe | May 1994 | A |
5346483 | Thaxton, Sr. | Sep 1994 | A |
5413117 | Wills | May 1995 | A |
5424265 | Weinstein | Jun 1995 | A |
5514091 | Yoon | May 1996 | A |
5674212 | Osborn et al. | Oct 1997 | A |
5693001 | Salama | Dec 1997 | A |
5957904 | Holland | Sep 1999 | A |
6120485 | Gustafsson et al. | Sep 2000 | A |
6151721 | Whitfield | Nov 2000 | A |
6183454 | Levine et al. | Feb 2001 | B1 |
6302303 | Reynolds | Oct 2001 | B1 |
6394988 | Hashimoto | May 2002 | B1 |
D467338 | Rehrig | Dec 2002 | S |
6544242 | Kido et al. | Apr 2003 | B1 |
6641567 | Williams | Nov 2003 | B1 |
6684414 | Rehrig | Feb 2004 | B1 |
6699174 | Bennett | Mar 2004 | B1 |
6702793 | Sweetser | Mar 2004 | B1 |
6740066 | Wolff et al. | May 2004 | B2 |
6761710 | D'acchioli et al. | Jul 2004 | B2 |
6840925 | Mishima et al. | Jan 2005 | B2 |
6849065 | Schmidt et al. | Feb 2005 | B2 |
6854427 | Frink | Feb 2005 | B2 |
6932797 | Schmidt et al. | Aug 2005 | B2 |
7018366 | Easter | Mar 2006 | B2 |
7358282 | Krueger et al. | Apr 2008 | B2 |
7465683 | McMurray | Dec 2008 | B2 |
7503911 | Mishima et al. | Mar 2009 | B2 |
7588560 | Dunlop | Sep 2009 | B1 |
7749205 | Tazoe et al. | Jul 2010 | B2 |
7766887 | Burns | Aug 2010 | B2 |
7875010 | Frazier et al. | Jan 2011 | B2 |
7931634 | Swiecicki et al. | Apr 2011 | B2 |
7993311 | Finger et al. | Aug 2011 | B2 |
8177760 | Rome et al. | May 2012 | B2 |
8187238 | Dupree | May 2012 | B1 |
8287508 | Sanchez | Oct 2012 | B1 |
8328792 | Nishtala et al. | Dec 2012 | B2 |
8394074 | Piette et al. | Mar 2013 | B2 |
8403901 | Dunlop | Mar 2013 | B2 |
8454568 | Bourke | Jun 2013 | B2 |
8603056 | Fallis | Dec 2013 | B1 |
8998882 | Knapp et al. | Apr 2015 | B2 |
9028460 | Medeiros | May 2015 | B2 |
9033149 | Terry | May 2015 | B2 |
10390989 | Sanchez et al. | Aug 2019 | B2 |
10682124 | Duvall | Jun 2020 | B2 |
10690655 | Duvall | Jun 2020 | B2 |
20020138058 | Mishima et al. | Sep 2002 | A1 |
20030004436 | Schmidt et al. | Jan 2003 | A1 |
20030010700 | Schmidt et al. | Jan 2003 | A1 |
20030185330 | Hessel et al. | Oct 2003 | A1 |
20030208112 | Schmidt et al. | Nov 2003 | A1 |
20040015141 | Cheng et al. | Jan 2004 | A1 |
20040035372 | Frink | Feb 2004 | A1 |
20040068780 | Scott | Apr 2004 | A1 |
20040079687 | Muller et al. | Apr 2004 | A1 |
20040138638 | Mishima et al. | Jul 2004 | A1 |
20040143229 | Easter | Jul 2004 | A1 |
20040236292 | Tazoe et al. | Nov 2004 | A1 |
20050075615 | Bonham | Apr 2005 | A1 |
20050101939 | Mitchell | May 2005 | A1 |
20050112975 | McMurray | May 2005 | A1 |
20050112976 | McMurray et al. | May 2005 | A1 |
20050137557 | Swiecicki et al. | Jun 2005 | A1 |
20060015080 | Mahnensmith | Jan 2006 | A1 |
20060069359 | Dipalma et al. | Mar 2006 | A1 |
20060155214 | Wightman | Jul 2006 | A1 |
20070035405 | Wada et al. | Feb 2007 | A1 |
20070265589 | Kitamura | Nov 2007 | A1 |
20080281282 | Finger et al. | Nov 2008 | A1 |
20080287894 | Van Den et al. | Nov 2008 | A1 |
20080300448 | Frazier et al. | Dec 2008 | A1 |
20090048569 | Salehi | Feb 2009 | A1 |
20090078023 | Mutharasan et al. | Mar 2009 | A1 |
20090131916 | Chiu et al. | May 2009 | A1 |
20090270822 | Medeiros | Oct 2009 | A1 |
20090306610 | Van Den et al. | Dec 2009 | A1 |
20100010459 | Piette et al. | Jan 2010 | A1 |
20100234820 | Tsai et al. | Sep 2010 | A1 |
20100274156 | Gorres | Oct 2010 | A1 |
20100278518 | Gordon | Nov 2010 | A1 |
20110028944 | Chiu et al. | Feb 2011 | A1 |
20110040271 | Rogers | Feb 2011 | A1 |
20110046514 | Greenwald et al. | Feb 2011 | A1 |
20110064586 | Matsumiya | Mar 2011 | A1 |
20110178425 | Nishtala et al. | Jul 2011 | A1 |
20110251572 | Nishtala et al. | Oct 2011 | A1 |
20110265889 | Tanaka et al. | Nov 2011 | A1 |
20150320583 | Harvie | Nov 2015 | A1 |
20160310711 | Luxon et al. | Oct 2016 | A1 |
20170280783 | Nouh | Oct 2017 | A1 |
20180031461 | Steckmann et al. | Feb 2018 | A1 |
20180188231 | Barakat et al. | Jul 2018 | A1 |
Number | Date | Country |
---|---|---|
19602299 | Jul 1997 | DE |
0613355 | Jan 1997 | EP |
0 951 881 | Jun 2000 | EP |
2001-087298 | Apr 2001 | JP |
2012-509489 | Nov 2008 | JP |
2010-166954 | Aug 2010 | JP |
2015-147040 | Aug 2015 | JP |
WO 1996011652 | Apr 1996 | WO |
WO 1997001316 | Jan 1997 | WO |
WO 2004019836 | Mar 2004 | WO |
WO 2005051252 | Jun 2005 | WO |
WO 2007058461 | May 2007 | WO |
WO 2008102808 | Aug 2008 | WO |
WO 2009004291 | Jan 2009 | WO |
WO 2017142723 | Aug 2017 | WO |
WO 2017142724 | Aug 2017 | WO |
Entry |
---|
Notice of Allowance issued in JP application No. 2018-543605, dated Jan. 5, 2021. |
Newman, D., Excerpts from The Urinary Incontinence Sourcebook, Lowell House, 1997, in 23 pages. |
International Search Report and Written Opinion issued in PCT Application No. PCT/US2017/016626, dated Apr. 21, 2017, in 7 pages. |
International Search Report and Written Opinion issued in PCT Application No. PCT/US2017/016624, dated Apr. 28, 2017, in 11 pages. |
International Preliminary Reporton Patentability issued in PCT Application No. PCT/US2017/016624, dated Aug. 21, 2018, in 9 pages. |
International Preliminary Reporton Patentability issued in PCT Application No. PCT/US2017/016626, dated Aug. 21, 2018, in 6 pages. |
Number | Date | Country | |
---|---|---|---|
20200345332 A1 | Nov 2020 | US |
Number | Date | Country | |
---|---|---|---|
62297096 | Feb 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15416272 | Jan 2017 | US |
Child | 16901614 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15412049 | Jan 2017 | US |
Child | 15416272 | US |